The latest study from the Jill Roberts Institute, "The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation," was published on September 6 in Nature. To read more, click here.     Dr. Gregory Sonnenberg wins inaugural award from the Society for Mucosal Immunology. To read more, click here.  The Kenneth Rainin Foundation awarded Dr. Iliyan Iliev and colleagues from Mount Sinai a $250,000 Synergy Award to examine the composition of the fungal community in babies born to mothers with inflammatory bowel disease. To read more, click here. Dr. Randy Longman received the Irma T. Hirschl Career Scientist Award and the New York Crohn’s Foundation Award.    

The Jill Roberts Institute for Research in Inflammatory Bowel Disease

You are here

Steven M. Lipkin, M.D., Ph.D.

Professor of Medicine and Genetic Medicine

Vice Chair for Basic and Translational Research

Dr. Lipkin is Professor of Medicine, Director of the Weill-Cornell Program in Mendelian Genetics, Director of the Adult and Cancer Genetics Clinic and Vice Chair for Basic and Translational Research in the Department of Medicine. He is a board certified clinical geneticist who sees patients with early onset and inherited gastrointestinal diseases, including inflammatory bowel disease. He trained in Internal Medicine at Duke University and Medical Genetics at the National Human Genome Research Institute. His research interests are the role of genetic mutations to cause genetic diseases, including inflammatory bowel disease and cancer.

 

Education and Training

  • University of California, San Diego School of Medicine 1995
  • B.A., Princeton University 1986

 

View Recent Publications

 

Grants awarded

Weill Cornell Medicine The Jill Roberts Institute for Research in Inflammatory Bowel Disease 413 E 69th Street, 7th Floor New York, NY 10021 Phone: (646) 962-6312